Soraya Fira, Sandhika Willy, Wiratama Priangga Adi
Department of Anatomic Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Medical Staff of Anatomic Pathology Laboratory, Dr Soetomo General Academic Hospital, Surabaya, Indonesia.
Asian Pac J Cancer Prev. 2025 Jan 1;26(1):301-307. doi: 10.31557/APJCP.2025.26.1.301.
Oxidative stress prompts breast cancer cells to adapt by raising the lethal threshold and enhancing the antioxidant mechanism, thereby enabling survival and continuous proliferation that facilitates tumor progression. Nrf2 and 8-OHdG are indicative of oxidative stress activity and impact the progression of breast cancer. We aimed to analyze the expression of Nrf2 and 8-OHdG in various T stages of breast cancer in our hospital.
This observational study employed a cross-sectional design and included patients with invasive breast carcinoma of no special type diagnosis from histopathology examination who underwent modified radical mastectomy without neoadjuvant chemotherapy at Dr. Soetomo General Academic Hospital between January 2019 and December 2022. Medical records and paraffin blocks that met these criteria were obtained. 8-OHdG and Nrf2 were assessed using immunohistochemistry.
There was no significant difference and correlation between 8-OHdG (p=0.578) and Nrf2 (p=0.694) expression with various T stages of IBC-NST and no significant correlation between 8-OHdG/Nrf2 expression and T stage (p=0.242 and 0.625 respectively).
Consistent expression of 8-OHdG and Nrf2 in various T stages of breast cancer represents a continuation of the oxidative stress process in breast cancer that is not influenced by the tumor size. The existence of consistent oxidative stress at all tumor sizes (T stage) stimulates breast cancer cells to continue proliferating.
氧化应激促使乳腺癌细胞通过提高致死阈值和增强抗氧化机制来适应,从而实现存活和持续增殖,促进肿瘤进展。Nrf2和8-羟基脱氧鸟苷(8-OHdG)是氧化应激活性的指标,并影响乳腺癌的进展。我们旨在分析我院不同T分期乳腺癌中Nrf2和8-OHdG的表达情况。
本观察性研究采用横断面设计,纳入2019年1月至2022年12月在苏托莫综合学术医院接受改良根治性乳房切除术且未接受新辅助化疗的非特殊类型浸润性乳腺癌组织病理学检查确诊患者。获取符合这些标准的病历和石蜡块。采用免疫组织化学法评估8-OHdG和Nrf2。
8-OHdG(p = 0.578)和Nrf2(p = 0.694)的表达与非特殊类型浸润性乳腺癌的不同T分期之间无显著差异和相关性,8-OHdG/Nrf2表达与T分期之间也无显著相关性(分别为p = 0.242和0.625)。
8-OHdG和Nrf2在乳腺癌不同T分期的一致表达代表了乳腺癌氧化应激过程的延续,不受肿瘤大小的影响。所有肿瘤大小(T分期)均存在一致的氧化应激刺激乳腺癌细胞持续增殖。